However, given both transgenic mouse models displayed clear STZ-induced beta-cell ablation, with distinct diabetes-induced alterations in islet cell transitioning (23, 32), they represent valid tools to assess the impact of sustained NPY1R agonism on alpha- to beta- and beta- to alpha-cell transdifferentiation. This evidence concerns the gene NPY1R and diabetes mellitus.